Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Skin cancer

SHTAC research projects are listed according to topic area.

Click on a topic area listed below to view associated publications. 

 

Cooper K, Harris P, Frampton G, Boehler C, Shepherd J. Cobimetinib in combination with vemurafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2016.

Cooper K, Kalita N, Streit E, Shepherd J, Chorozoglou M, Frampton G. Nivolumab for treating advanced (unresectable or metastatic) melanoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2015.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×